These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 9758259)

  • 21. Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial.
    Laskin CA; Spitzer KA; Clark CA; Crowther MR; Ginsberg JS; Hawker GA; Kingdom JC; Barrett J; Gent M
    J Rheumatol; 2009 Feb; 36(2):279-87. PubMed ID: 19208560
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aspirin or anticoagulants for treating recurrent miscarriage in women without antiphospholipid syndrome.
    Kaandorp S; Di Nisio M; Goddijn M; Middeldorp S
    Cochrane Database Syst Rev; 2009 Jan; (1):CD004734. PubMed ID: 19160241
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pre-pregnant prediction of recurrent preeclampsia in normotensive thrombophilic formerly preeclamptic women receiving prophylactic antithrombotic medication.
    Spaanderman ME; Aardenburg R; Ekhart TH; van Eyndhoven HW; de Leeuw PW; Peeters LL
    J Soc Gynecol Investig; 2005 Feb; 12(2):112-7. PubMed ID: 15695106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pravastatin is useful for prevention of recurrent severe placenta-mediated complications - a pilot study.
    Kupferminc MJ; Kliger C; Rimon E; Asher-Landsberg J; Skornick-Rapaport A; Gamzu R; Yogev Y
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):8055-8061. PubMed ID: 34154497
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anticoagulants to prevent recurrent placenta-mediated pregnancy complications: Is it time to put the needles away?
    Skeith L; Rodger M
    Thromb Res; 2017 Mar; 151 Suppl 1():S38-S42. PubMed ID: 28262232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Thrombophilias and vascular placental pathology. A survey of the literature].
    Verspyck E; Marpeau L
    Rev Med Interne; 2005 Feb; 26(2):103-8. PubMed ID: 15710256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thromboprophylaxis in pregnant women with thrombophilia and a history of thrombosis.
    Akinshina S; Makatsariya A; Bitsadze V; Khizroeva J; Khamani N
    J Perinat Med; 2018 Oct; 46(8):893-899. PubMed ID: 29949514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Anticoagulation and antiaggregation during pregnancy].
    Biasiutti FD; Strebel JK
    Ther Umsch; 2003 Jan; 60(1):54-8. PubMed ID: 12638480
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prophylaxis of recurrent preeclampsia: low-molecular-weight heparin plus low-dose aspirin versus low-dose aspirin alone.
    Sergio F; Maria Clara D; Gabriella F; Giorgia S; Sara De Carolis ; Giancarlo P; Alessandro C
    Hypertens Pregnancy; 2006; 25(2):115-27. PubMed ID: 16867918
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Understanding and Preventing Placenta-Mediated Pregnancy Complications.
    Skeith L; Blondon M; Ní Áinle F
    Hamostaseologie; 2020 Aug; 40(3):356-363. PubMed ID: 32726830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Triple therapy with pravastatin, low molecular weight heparin and low dose aspirin improves placental haemodynamics and pregnancy outcomes in obstetric antiphospholipid syndrome in mice and women through a nitric oxide-dependent mechanism.
    Lefkou E; Varoudi K; Pombo J; Jurisic A; Jurisic Z; Contento G; Girardi G
    Biochem Pharmacol; 2020 Dec; 182():114217. PubMed ID: 32926874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does low-molecular-weight heparin improve live birth rates in pregnant women with thrombophilic disorders? A systematic review.
    Tan WK; Lim SK; Tan LK; Bauptista D
    Singapore Med J; 2012 Oct; 53(10):659-63. PubMed ID: 23112017
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Placenta-mediated pregnancy complications in women with a history of late fetal loss and placental infarction without thrombophilia: risk of recurrence and efficacy of pharmacological prophylactic interventions. A 10-year retrospective study.
    Borella F; Marozio L; Bertschy G; Botta G; Bertero L; Cassoni P; Maina A; Cosma S; Benedetto C
    J Matern Fetal Neonatal Med; 2023 Dec; 36(1):2183748. PubMed ID: 36860098
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enoxaparin for the prevention of preeclampsia and intrauterine growth restriction in women with a prior history - an open-label randomised trial (the EPPI trial): study protocol.
    Groom KM; McCowan LM; Stone PR; Chamley LC; McLintock C;
    BMC Pregnancy Childbirth; 2016 Nov; 16(1):367. PubMed ID: 27876004
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low-molecular-weight heparin and aspirin in the prevention of recurrent early-onset pre-eclampsia in women with antiphospholipid antibodies: the FRUIT-RCT.
    van Hoorn ME; Hague WM; van Pampus MG; Bezemer D; de Vries JI;
    Eur J Obstet Gynecol Reprod Biol; 2016 Feb; 197():168-73. PubMed ID: 26771908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
    Bates SM; Greer IA; Pabinger I; Sofaer S; Hirsh J
    Chest; 2008 Jun; 133(6 Suppl):844S-886S. PubMed ID: 18574280
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [ANTITHROMBOTIC MEDICATION IN PREGNANT WOMEN WITH PREVIOUS INTRAUTERINE GROWTH RESTRICTION].
    Neykova K; Dimitrova V; Dimitrov R; Vakrilova L
    Akush Ginekol (Sofiia); 2016; 55(2):3-9. PubMed ID: 27509650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Our experience with management of inherited thrombophilia during pregnancy: preliminary report].
    Marinov B; Pramatarova T; Andreeva A; Iarukova N; Slavov A
    Akush Ginekol (Sofiia); 2011; 50 Suppl 2():28-31. PubMed ID: 22524136
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of aspirin, heparin, and other interventions in the prevention and treatment of fetal growth restriction.
    Groom KM; David AL
    Am J Obstet Gynecol; 2018 Feb; 218(2S):S829-S840. PubMed ID: 29229321
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiogenic Factor Profiles in Pregnant Women With a History of Early-Onset Severe Preeclampsia Receiving Low-Molecular-Weight Heparin Prophylaxis.
    Lecarpentier E; Gris JC; Cochery-Nouvellon E; Mercier E; Touboul C; Thadhani R; Karumanchi SA; Haddad B
    Obstet Gynecol; 2018 Jan; 131(1):63-69. PubMed ID: 29215518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.